|
2019 Conference Publication Value for money of putting precision into practice: Germline genetic testing to guide olaparib treatment in HER2-negative metastatic breast cancerTuffaha, Haitham and Scuffham, Paul (2019). Value for money of putting precision into practice: Germline genetic testing to guide olaparib treatment in HER2-negative metastatic breast cancer. COSA's 46th Annual Scientific Meeting, Urological cancer; Age and gender in cancer practice; Digital health in cancer, Adelaide, Australia, 12–14 November 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13262 |
|
2019 Conference Publication PCN95 cost-effectiveness analysis of germline BRCA mutation testing and olaparib treatment in metastatic breast cancer: an evaluation of codependent technologiesTuffaha, H. and Scuffham, P. (2019). PCN95 cost-effectiveness analysis of germline BRCA mutation testing and olaparib treatment in metastatic breast cancer: an evaluation of codependent technologies. ISPOR Europe 2019, Copenhagen, Denmark, 2-6 November 2019. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2019.09.292 |
|
2018 Journal Article Directing research funds to the right research projects: a review of criteria used by research organisations in Australia in prioritising health research projects for fundingTuffaha, Haitham W., El Saifi, Najwan, Chambers, Suzanne K. and Scuffham, Paul A. (2018). Directing research funds to the right research projects: a review of criteria used by research organisations in Australia in prioritising health research projects for funding. BMJ Open, 8 (12) e026207, e026207. doi: 10.1136/bmjopen-2018-026207 |
|
2018 Other Outputs Implementation of GCPHN Evaluation Framework – COPD After Hours and Persistent Pain ProgramVecchio, Nerina, Tuffaha, Haitham, Radford, Katrina and Chai, Andreas (2018). Implementation of GCPHN Evaluation Framework – COPD After Hours and Persistent Pain Program. Gold Coast, QLD, Australia: Griffith University. |
|
2018 Journal Article Cost of vascular access devices in public hospitals in QueenslandTuffaha, Haitham W., Marsh, Nicole, Byrnes, Joshua, Gavin, Nicole, Webster, Joan, Cooke, Marie and Rickard, Claire M. (2018). Cost of vascular access devices in public hospitals in Queensland. Australian Health Review, 43 (5), 511-515. doi: 10.1071/AH18102 |
|
2018 Journal Article Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trialRickard, Claire M., Marsh, Nicole, Webster, Joan, Runnegar, Naomi, Larsen, Emily, McGrail, Matthew R., Fullerton, Fiona, Bettington, Emilie, Whitty, Jennifer A., Abu Choudhury, Md, Tuffaha, Haitham, Corley, Amanda, McMillan, David J., Fraser, John F., Marshall, Andrea P. and Playford, E. Geoffrey (2018). Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial. Lancet, 392 (10145), 419-430. doi: 10.1016/S0140-6736(18)31380-1 |
|
2018 Journal Article Medication adherence in older patients with dementia: a systematic literature reviewEl-Saifi, Najwan, Moyle, Wendy, Jones, Cindy and Tuffaha, Haitham (2018). Medication adherence in older patients with dementia: a systematic literature review. Journal of Pharmacy Practice, 31 (3), 322-334. doi: 10.1177/0897190017710524 |
|
2018 Journal Article The Australian managed entry scheme: are we getting it right?Tuffaha, Haitham W. and Scuffham, Paul A. (2018). The Australian managed entry scheme: are we getting it right?. Pharmacoeconomics, 36 (5), 555-565. doi: 10.1007/s40273-018-0633-6 |
|
2018 Journal Article Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysisGordon, Louisa G., Tuffaha, Haitham W., James, Robbie, Keller, Andrew T., Lowe, Anthony, Scuffham, Paul A. and Gardiner, Robert A. (2018). Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis. Urologic Oncology, 36 (3) 91.e7, e7-e15. doi: 10.1016/j.urolonc.2017.10.024 |
|
2018 Journal Article Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriersTuffaha, Haitham W., Mitchell, Andrew, Ward, Robyn L., Connelly, Luke, Butler, James R. G., Norris, Sarah and Scuffham, Paul A. (2018). Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 20 (9), 985-994. doi: 10.1038/gim.2017.231 |
|
2018 Conference Publication Value For Money, the Overlooked Aspect in Research Funding DecisionsTuffaha, H., El-Saifi, N. and Scuffham, P. (2018). Value For Money, the Overlooked Aspect in Research Funding Decisions. Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia-Pacific, Tokyo, Japan, 8-11 September 2018. Elsevier. doi: 10.1016/j.jval.2018.07.413 |
|
2018 Conference Publication Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in AustraliaTuffaha, H. and Scuffham, P. (2018). Rare Cancers, no Rare Solutions: Risk Sharing Arrangemnts to Reimburse Medicines for Rare Cancers in Australia. Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia-Pacific, Tokyo, Japan, 8-11 September 2018. Elsevier. doi: 10.1016/j.jval.2018.07.839 |
|
2018 Conference Publication Can we prospectively assess the value for money of oncology clinical trials?Tuffaha, Haitham, Chambers, Suzanne and Scuffham, Paul (2018). Can we prospectively assess the value for money of oncology clinical trials?. COSA's 45th Annual Scientific Meeting, Mesothelioma and Gastro‐Intestinal Cancers: Technology and Genomics, Perth, WA Australia, 13–15 November 2018. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.13089 |
|
2018 Conference Publication Can technology improve medication adherence in older people with dementia?El-Saifi, Najwan, Moyle, Wendy, Jones, Cindy and Tuffaha, Haitham (2018). Can technology improve medication adherence in older people with dementia?. 16th International Conference, ICOST 2018, Singapore, 10-12 July, 2018. Cham, Switzerland: Springer. doi: 10.1007/978-3-319-94523-1_1 |
|
2017 Conference Publication INTERNATIONAL HTA EXPERIENCE WITH TARGETED THERAPY APPROVALS FOR LUNG CANCERMaraiki, R., Bymes, J., Tuffaha, H. and Hider, M. (2017). INTERNATIONAL HTA EXPERIENCE WITH TARGETED THERAPY APPROVALS FOR LUNG CANCER. NEW YORK: ELSEVIER SCIENCE INC. |
|
2017 Journal Article A program to increase research productivity among hospital pharmacistsNazer, Lama H., Tuffaha, Haitham and Jaddoua, Saad (2017). A program to increase research productivity among hospital pharmacists. Journal of Pharmacy Practice, 30 (3), 336-341. doi: 10.1177/0897190016645432 |
|
2017 Journal Article Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in AustraliaGordon, Louisa G., James, Robbie, Tuffaha, Haitham W., Lowe, Anthony and Yaxley, John (2017). Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia. Journal of Magnetic Resonance Imaging, 45 (5), 1304-1315. doi: 10.1002/jmri.25504 |
|
2017 Journal Article Health care and pharmacy practice in JordanNazer, Lama H. and Tuffaha, Haitham (2017). Health care and pharmacy practice in Jordan. Canadian Journal of Hospital Pharmacy, 70 (2), 150-155. doi: 10.4212/cjhp.v70i2.1649 |
|
2017 Journal Article Setting medical research future fund priorities: assessing the value of researchTuffaha, Haitham W., Andronis, Lazaros and Scuffham, Paul A. (2017). Setting medical research future fund priorities: assessing the value of research. Medical Journal of Australia, 206 (2), 64-65.e1. doi: 10.5694/mja16.00672 |
|
2017 Conference Publication International HTA experience with targeted therapy approvals For lung cancerMaraiki, F., Byrnes, J., Tuffaha, H. and Hider, M. (2017). International HTA experience with targeted therapy approvals For lung cancer. ISPOR 20th Annual European Congress, Glasgow, United Kingdom, 4-8 November 2017. New York, NY USA: Elsevier. doi: 10.1016/j.jval.2017.08.335 |
